Vaccine effectiveness against prevalent anal and oral human papillomavirus infection among men who have sex with men - United States, 2016-2018

Elissa Meites*, Rachel L. Winer, Michael E. Newcomb, Pamina M. Gorbach, Troy D. Querec, Jessica Rudd, Tom Collins, John Lin, Janell Moore, Thomas Remble, Fred Swanson, Justin Franz, Robert K. Bolan, Matthew R. Golden, Brian Mustanski, Richard A. Crosby, Elizabeth R. Unger, Lauri E. Markowitz

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

Background: In the United States, human papillomavirus (HPV) vaccination has been recommended for young adult men who have sex with men (MSM) since 2011. Methods: The Vaccine Impact in Men study surveyed MSM and transgender women aged 18-26 years in 3 US cities during 2016-2018. Self-collected anal swab and oral rinse specimens were assessed for 37 types of HPV. We compared HPV prevalence among vaccinated and unvaccinated participants and determined adjusted prevalence ratios (aPR) and 95% confidence intervals (CI). Results: Among 1767 participants, 704 (39.8%) self-reported receiving HPV vaccine. Median age at vaccination (18.7 years) was older than age at first sex (15.7 years). Quadrivalent vaccine-type HPV was detected in anal or oral specimens from 475 (26.9%) participants. Vaccine-type HPV prevalence was lower among vaccinated (22.9%) compared with unvaccinated (31.6%) participants; aPR for those who initiated vaccination at age ≤18 years was 0.41 (CI, 0.24-0.57) and at age >18 years was 0.82 (CI, 0.67-0.98). Vaccine effectiveness of at least 1 HPV vaccine dose at age ≤18 years or >18 years was 59% and 18%, respectively. Conclusions: Findings suggest real-world effectiveness of HPV vaccination among young adult MSM. This effect was stronger with younger age at vaccination.

Original languageEnglish (US)
Pages (from-to)2052-2060
Number of pages9
JournalJournal of Infectious Diseases
Volume222
Issue number12
DOIs
StatePublished - Dec 15 2020

Keywords

  • Papillomavirus infections
  • Papillomavirus vaccines
  • Sexual and gender minorities
  • Vaccination

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Vaccine effectiveness against prevalent anal and oral human papillomavirus infection among men who have sex with men - United States, 2016-2018'. Together they form a unique fingerprint.

Cite this